SPRUCE BIOSCIENCES, INC. (SPRB) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	8-K	10-K	8-K	10-K	10-K	S-1/A
Revenues	0.0	35.2	0.0	30.7	0.0	0.0	8.4
Revenue growth		14.7%				-100.0%
Cost of goods sold	0.0	47.3	0.0	42.1	0.0	0.0	10.0
Gross profit	0.0	-12.1	0.0	-11.4	0.0	0.0	-1.6
Gross margin		-34.3%		-37.0%			-18.7%
Selling, general and administrative [+]	12.1	12.1	11.4	11.4	5.6	2.3	1.6
General and administrative	12.1	12.1	11.4	11.4	5.6	2.3	1.6
Research and development	35.2		30.7		23.9	10.8
Other operating expenses		23.1		19.3			6.8
EBITDA [+]	-47.2		-42.0		-29.4	-13.1	-10.0
EBITDA growth	12.4%	12.4%	42.9%		124.4%	31.3%
EBITDA margin		-134.3%		-137.0%			-118.7%
Depreciation and amortization	0.1		0.1		0.0	0.0	0.0
EBIT [+]	-47.3	-47.3	-42.1	-42.1	-29.4	-13.1	-10.0
EBIT growth	12.4%	12.4%	43.0%		124.4%	31.4%
EBIT margin		-134.3%		-137.0%			-118.7%
Interest expense	0.4	0.4	0.3	0.3	0.3	0.1
Interest expense	0.4	0.4	0.3	0.3	0.3	0.1
Other income (expense), net [+]	1.5	1.5	0.1	0.1	0.2	0.1	0.1
Gain (loss) on investments		-0.4		-0.2
Other					0.2	0.1	0.1
Pre-tax income	-46.2	-46.2	-42.3	-42.3	-29.5	-13.1	-9.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-46.2	-46.2	-42.3	-42.3	-29.5	-13.1	-9.9
Net margin		-131.2%		-137.8%			-117.3%

Basic EPS [+]	($1.96)	($1.96)	($1.81)	($1.81)	($4.93)	($17.12)	($13.12)
Growth	8.4%	8.4%	-63.3%		-71.2%	30.5%
Diluted EPS [+]	($1.96)	($1.96)	($1.81)	($1.81)	($4.93)	($17.12)	($13.12)
Growth	8.4%	8.4%	-63.3%		-71.2%	30.5%

Shares outstanding (basic) [+]	23.5	23.5	23.4	23.4	6.0	0.8	0.8
Growth	0.7%	0.7%	289.9%		683.8%	1.8%
Shares outstanding (diluted) [+]	23.5	23.5	23.4	23.4	6.0	0.8	0.8
Growth	0.7%	0.7%	289.9%		683.8%	1.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.